30 Day Insulin Balance Metabolic Health Optimization Protocol
Efforia, Inc · NCT07478497
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- October 21, 2025
- Record last updated
- March 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Explore how a dietary supplement can help support healthy insulin levels and its impact on weight, fatigue, and sugar cravings. The Insulin Balance Formula and Hormetics Weight Optimization System is designed for people who are generally healthy and want to support and maintain healthy insulin levels to reach general health goals.
Being studied: Insulin Balance Formula - Hormetics Weight Optimization System
Conditions: Insulin
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Adults 18+ who are generally healthy
- Ability to read and comprehend English
- Ability to willfully consent and follow study procedures and tasks
Exclusion Criteria
- Individuals with Known Allergies
- Pregnant or Nursing Individuals
- Individuals with Insulin Disorders
- Individuals with GI Disorders
- Individuals with Mental Health Conditions
- Individuals with Sleep Disorders
- Individuals on Medication
- Athletes under Specific Regulations
- Individuals Sensitive to Fatigue
Recruiting US locations
Efforia
New York, NY 10003
Site contact: Matthew Amsden · (646) 679-2479 · help@efforia.com
Study contacts (from the official record)
- Matthew Amsden · (646) 679-2479 · help@efforia.com
Similar studies in New York
All diabetes studies in New York →- RecruitingPhase 1Overnight stay mentioned
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
GentiBio, Inc
- Location
- New York, NY + 8 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Alpelisib Challenge Test (ACT)
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Columbia University
- Location
- New York, NY
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- The Bronx, NY + 55 other US sites
- Eligibility basics
- Ages 18–79